Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Clin Oncol (R Coll Radiol). 2012 May;24(4):e63-70. doi: 10.1016/j.clon.2011.06.008. Epub 2011 Jul 12.
To compare the dose to organs at risk (OAR) between a conventional four-field whole pelvis radiotherapy (4F-WPRT) plan and an initial single intensity-modulated WPRT (IM-WPRT) plan for definitive treatment of cervical cancer. The magnitude of potential dose sparing of OAR is unknown when planning target volumes are defined to include potential organ motion and microscopic disease extent.
Planning computed tomography scans of 50 consecutive, previously treated patients were re-planned using 4F-WPRT and IM-WPRT. Margins compatible with the literature on organ motion were used to create the planning target volume. Dose-volume histograms for target and OAR were compared for each patient with paired t-tests and waterfall plots.
The mean target volume covered by 95% (V47.8) was 99.7% for 4F-WPRT and 98.8% for IM-WPRT (P>0.05, ns). Intensity-modulated radiotherapy (IMRT) was associated with a significant reduction in the dose to OAR at the V50, V45, V40 and V30 level. There was a >20% difference in V50 in most patients: 84% (bladder), 58% (small bowel), 54% (sigmoid) and 84% (rectum).
A single, initial IMRT plan with appropriate margins encompassing initial gross and potential microscopic pelvic disease leads to a reduction in the dose to OAR without compromising target coverage. This offers a potential 'class solution' for definitive treatment of patients with cervical cancer. Clinical outcome data are still needed to verify this planning study.
比较宫颈癌根治性治疗中常规四野全骨盆放疗(4F-WPRT)计划和初始单野调强全骨盆放疗(IM-WPRT)计划中危及器官(OAR)的剂量。当计划靶区包括潜在器官运动和微观疾病范围时,OAR 潜在剂量节省的幅度尚不清楚。
对 50 例连续接受过治疗的患者的计划 CT 扫描进行重新规划,分别采用 4F-WPRT 和 IM-WPRT 进行规划。使用与器官运动文献兼容的边界来创建计划靶区。对每位患者进行配对 t 检验和瀑布图比较靶区和 OAR 的剂量体积直方图。
4F-WPRT 的 95%(V47.8)靶区体积覆盖率为 99.7%,IM-WPRT 为 98.8%(P>0.05,无统计学意义)。调强放疗(IMRT)与 OAR 剂量的显著降低有关,V50、V45、V40 和 V30 水平的剂量降低。在大多数患者中,V50 差异>20%:84%(膀胱)、58%(小肠)、54%(乙状结肠)和 84%(直肠)。
初始 IMRT 计划具有适当的边界,包含初始大体和潜在的盆腔微观疾病,可在不影响靶区覆盖的情况下降低 OAR 剂量。这为宫颈癌患者的根治性治疗提供了一种潜在的“标准解决方案”。仍需要临床结果数据来验证这项计划研究。